Complement modulatory activity of bisbenzylisoquinoline alkaloids isolated from Isopyrum thalictroides -: II Influence on C3-9 reactions in vitro and antiinflammatory effect in vivo

被引:11
作者
Ivanovska, N [1 ]
Hristova, M
Philipov, S
机构
[1] Bulgarian Acad Sci, Inst Microbiol, Sofia 1113, Bulgaria
[2] Bulgarian Acad Sci, Inst Organ Chem, Ctr Phytochem, Sofia 1113, Bulgaria
来源
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1999年 / 21卷 / 05期
关键词
bisbenzylisoquinolines; complement activity; C3; cleavage; inflammatory models;
D O I
10.1016/S0192-0561(99)00015-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The main alkaloids isopyruthaline (It1), fangchinoline (It2) and isothalictrine (It3), isolated from Isopyrum thalictroides (L.) were investigated in complement-mediated reactions. The alkaloids influenced the alternative pathway (AP) activity in normal human serum (NHS). They enhanced the inhibitory action of complement activators-carrageenan (Car), zymosan (Zy), hydrogen peroxide (HP) and high temperature via classical pathway (CP) in NHS. Substances strongly potentiated the action of zymosan and cobra venom (CV) in guinea pig serum (GPS). It was established that they could provoke C3 conversion in NHS and mouse sera (MS). The antiinflammatory properties of the alkaloids were evaluated in mouse paw oedema induced by CV, Zy and histamine (His). Isopyruthaline and isothalictrine suppressed paw swelling in CV- and Zy-oedema. They were applied in Zy-induced multiple organ dysfunction syndrome (MODS) in mice. The alkaloids inhibited the increase of the serum complement activity provoked by the injection of zymosan. It1 lowered the mortality rate of mice with MODS if its application proceeded Zy. An increase of the number of mice without tissue injury was established after treatment with It1 and It3. (C) 1999 International Society for Immunopharmacology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:337 / 347
页数:11
相关论文
共 16 条
[1]   COMPLEMENT COMPONENT C5 MODULATES THE SYSTEMIC TUMOR-NECROSIS-FACTOR RESPONSE IN MURINE ENDOTOXIC-SHOCK [J].
BARTON, PA ;
WARREN, JS .
INFECTION AND IMMUNITY, 1993, 61 (04) :1474-1481
[2]  
DIJK H, 1986, IMMUNOL LETT, V12, P281
[3]  
Edens E, 1993, COMPLEMENT PROFILES, V1, P96
[4]   HEPARIN AND DERIVATIZED HEPARIN INHIBIT ZYMOSAN AND COBRA VENOM FACTOR ACTIVATION OF COMPLEMENT IN SERUM [J].
EDENS, RE ;
LINHARDT, RJ ;
BELL, CS ;
WEILER, JM .
IMMUNOPHARMACOLOGY, 1994, 27 (02) :145-153
[5]   INVITRO STUDIES ON COMPLEMENT INACTIVATION BY SNAKE-VENOMS [J].
EGGERTSEN, G ;
FOHLMAN, J ;
SJOQUIST, J .
TOXICON, 1980, 18 (01) :87-+
[6]  
GOODMAN MG, 1982, J IMMUNOL, V129, P70
[7]   Complement modulatory activity of bisbenzylisoquinoline alkaloids isolated from Isopyrum thalictroides -: I Influence on classical pathway in human serum [J].
Ivanovska, N ;
Nikolova, P ;
Hristova, M ;
Philipov, S ;
Istatkova, R .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1999, 21 (05) :325-336
[8]   MICRO-ASSAY FOR COLORIMETRIC ESTIMATION OF COMPLEMENT ACTIVITY IN GUINEA-PIG, HUMAN AND MOUSE SERUM [J].
KLERX, JPAM ;
BEUKELMAN, CJ ;
VANDIJK, H ;
WILLERS, JMN .
JOURNAL OF IMMUNOLOGICAL METHODS, 1983, 63 (02) :215-220
[9]  
LAMBRIS JD, 1988, IMMUNOL TODAY, V8, P261
[10]   A NEW MODEL OF ACUTE-INFLAMMATION - COBRA VENOM FACTOR INDUCED PAW EDEMA [J].
LEYCK, S ;
ETSCHENBERG, E ;
HADDING, U ;
WINKELMANN, J .
AGENTS AND ACTIONS, 1983, 13 (5-6) :437-438